Omega-3 and ADHD: What the Trials Found, Summarized Without the Hype
Who was tested, for how long, how big the effects were in plain language, why adult data is thin, and the questions worth asking a prescriber first.

The supplement aisle has a shelf of fish oil with brain-shaped logos, and the price runs from 12 dollars to 60. A podcast said omega-3 is as good as medication. A forum said it did nothing. Your pharmacist shrugged. You would like to know what the actual trials found before you spend another 40 dollars a month on hope.
This is a plain summary of the omega-3 ADHD evidence: who was studied, what changed, how much, and where the gaps are. It is not an argument for or against the capsules. It is the information you need to have a useful ten-minute conversation with a prescriber, which is where this decision belongs.
What was tested, in whom, and for how long
Nearly all of the trials used fish-oil capsules delivering the two long-chain omega-3 fatty acids, EPA and DHA, at doses somewhere between a few hundred milligrams and a little over a gram a day combined. Some trials used formulas weighted toward EPA, others toward DHA, and a few added omega-6 fats as well. The comparison was usually a placebo oil such as olive or sunflower.
The participants were overwhelmingly children, mostly aged 6 to 12, most with a formal ADHD diagnosis and some already on medication. Trials ran for 8 to 16 weeks in most cases, with a few stretching to six months. The main outcome was almost always a parent or teacher rating scale of ADHD symptoms, sometimes with a computer attention task added. Those three facts, children, a few months, rating scales, shape everything that follows.
Effect sizes in plain language: small, mixed, and mostly in children
When trials are pooled, the result has been fairly consistent across reviews. A 2011 meta-analysis of ten trials in children found a small overall improvement in symptom ratings, around a third of a standard deviation, with higher EPA doses linked to slightly larger effects. A 2013 review that looked at many non-drug treatments found a similar small effect for fatty acid supplementation, and notably it was one of the few that held up when the ratings came from people who did not know what the child was taking. A 2018 meta-analysis again reported small improvements in symptom ratings and in some attention measures.
What does a third of a standard deviation mean in a kitchen? On a typical 18-item symptom scale, it is a change of a few points, enough that a careful parent might notice a somewhat better month and might not. It is well short of what families usually mean when they ask whether something works. Individual trials were mixed: some positive, several null, and the larger and better-run ones tended to be the more modest. Nothing in this literature supports the claim that omega-3 is comparable to prescribed treatment, and Canadian ADHD guidelines do not list it among recommended treatments.
Why adult data is thin
If you are an adult, the evidence base shrinks to a handful of small trials, most under 100 people, most short, and most with results that could be read either way. There are ordinary reasons for this. Children have been the main focus of ADHD research for decades. Supplement trials are expensive to run well and rarely attract funding. And adult ADHD comes with more variation in sleep, diet, work and other conditions, which makes a small effect harder to detect.
So the honest statement for adults is not that omega-3 does not work. It is that nobody has done the study that would tell us, and the children's data suggest that if there is an effect, it is small. If you have read our post on supplements and natural remedies for ADHD, omega-3 sits near the top of that list precisely because it has been tested at all; most of the aisle has not.
Quality, dose and product problems the trials do not solve
Even if you decided the small effect was worth chasing, the capsule in your hand is not the capsule in the trial. A few practical problems sit between the research and the shelf.
- Dose is on the back, not the front. A capsule labelled 1,000 mg of fish oil may contain 300 mg of EPA and DHA combined. The trials counted the latter. Read the fine print, and do the math on how many capsules the trial dose would actually mean.
- Ratios differ. Products range from DHA-heavy to EPA-heavy. The trial signal, such as it is, leaned toward EPA.
- Quality varies. In Canada, look for a Natural Product Number on the label. An NPN means Health Canada has reviewed the product for safety, quality and the claims it makes. It does not mean the product treats ADHD; it means the bottle contains what it says.
- Oil goes off. Fish oil oxidises. Capsules that smell strongly or taste rancid are past their useful life. Buy smaller bottles and keep them cool.
- It is not free of interactions. High doses can affect bleeding, which matters if you take blood-thinning medication or have surgery coming up. Fish allergy matters too. Tell your pharmacist what you are taking.
- It costs real money. A trial-level dose from a decent product runs 20 to 40 dollars a month in Canada, and benefits plans do not cover it. Over a year that is a few hundred dollars, which is worth weighing against a small and uncertain effect.
Questions to bring to your prescriber instead of the supplement aisle
The decision gets a lot easier with a clinician in the room, especially if omega-3 is standing in for a conversation about treatment you have been putting off. The answer on non-medication treatment options for ADHD lays out what else is on the table. Then ask these:
- Given my age and situation, is there any reason omega-3 is likely to matter for me, or is this a low-priority add-on?
- Is there anything in my health history or my other medications that makes fish oil a bad idea?
- If I try it, what dose and for how long before we agree it did nothing?
- What would we measure? A symptom scale at the start and at three months, or something else?
- What am I actually hoping it will do, and is there a treatment with better evidence for that specific thing?
If you do not have a prescriber to ask, Finding Focus offers online ADHD assessment and treatment for adults and teens in several Canadian provinces, one consultation with a licensed Canadian clinician after a short online intake, no referral needed. Details are on the ADHD services page. Bring the bottle, or the screenshot of the one you were about to buy. It makes a better conversation than a podcast quote.
References
- 1.Bloch, M. H., and Qawasmi, A. (2011). Omega-3 fatty acid supplementation for the treatment of children with attention-deficit/hyperactivity disorder symptomatology: systematic review and meta-analysis. Journal of the American Academy of Child and Adolescent Psychiatry. View source ↗
- 2.Sonuga-Barke, E. J. S., Brandeis, D., Cortese, S., et al. (2013). Nonpharmacological interventions for ADHD: systematic review and meta-analyses of randomized controlled trials of dietary and psychological treatments. American Journal of Psychiatry. View source ↗
- 3.Chang, J. P.-C., Su, K.-P., Mondelli, V., and Pariante, C. M. (2018). Omega-3 polyunsaturated fatty acids in youths with attention deficit hyperactivity disorder: a systematic review and meta-analysis of clinical trials and biological studies. Neuropsychopharmacology. View source ↗
- 4.CADDRA (2020). Canadian ADHD Practice Guidelines, 4.1 edition. View source ↗
This article is for educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional about your individual situation. If you are in crisis or thinking about self-harm, call or text 9-8-8, Canada’s Suicide Crisis Helpline, at any time.
Finding Focus uses AI tools to help research and draft some articles. Every article is edited and fact-checked by the Finding Focus team before publication. See our editorial and medical review policy.




